: <r 3M General Offices. 3LMpaCenteree,IA2-/50F CASI Cg 0p.
refid# oerOYQrm1mMxQL6Q8pevxXX3 pages
AR226-2174 DISPERSION MODELING PROTOCOL Fluoropolymers Plant-APFO Emissions DuPont Washington Works Prepared by: Debbie J.
refid# rxLExxyoJmL2kbzawvD902YkV3 pages
AR226-2471 DiiPofti WsshiBpon Woiks P. 0.
refid# 068XXoJmwYmeoJmneRNJNYapk4 pages
?
refid# 5DKEoxYG7xeQOQBKjOd2yJ8pD4 pages
. . . , 301 Spestaley Matern ff SKgerFeronneA20S0s314-401000\0L-072% ARRR6 _35<57 mE VIA UPS Document Control Office (DCO) Office of Pollution Prevention and Toxics (OPPT) US Environmental Protection Agency [1E2P0A1 ECaosnts,tiRtoutoimon6A4v2e8nue, MW Washington DC 20460 Attention: Docket No.
refid# DK3p7GxXwxbnzn585bzDLKo413 pages
.
refid# kXJ5eGvYY4Lq4BLdNaM3oKBJ3 pages
TSCA Section 8(e) Office z 26 _ 37~ P. 1 October 23, 2006 Page 3 Attachment 1 First Chemical Corporation - Pascagoula, Mississipp i 2006 Update - Employee Blood Serum Results = Summary Job Name ~.
refid# 37eJoorpa13q6Z47ok5OJam03 pages
3M General Offices 3M Center p. 1 St.
refid# MGqmnbB2N1KDvrkkZxDnBKRQ71 page
Ja LT ---------- 1 FTor.om: DaSutbej:ect: KBaorroosn.RFuosllso, ty FVodn, TMayR14A, 20N07S1--1:M1a2r3Ii0nTPATTSyAstLem Remaining Data [ >Hi>>kaWrionk,am B Robertson Wiliam B Robertson@USA dupont com> 11412007 848 AM >>> A`latnacchle!
refid# 5kDG6xrV5qLjMJdzOYBRg90903 pages
Ceas 7 on Ss27 e ho m FYI 2 0AR5D0.0-10327084 3M May 18,, 2000 FYI-00-001378 MR =2z 61% s = Rx 535a= VIA EXPRESS MAIL DDri.reCchtaorrles Auer Chemical Control Division UOfnfiitceedOSftaPtoelsluEtinovnirPornemveennttaiolnPArontdecTtoixoincAsgency R40o1omM4S0tr3eeEta,sStoTuotwhewres(tMail Code 7405) Washington, D.
refid# NwDwb698Ky2wz1mLywvgz29851 pages
Do : AR226- 1088 3CMoCmopmapannyy FINAL REPORT Epidemiology, 220-3W-05 Medical Department 3M Company St.
refid# VGL9V8wwjgZGgnV18zxJ9X3V863 pages
.
refid# G5w2mmo50b9db6b34begpv87x12 pages
TELOMER RESEARCH PROGRAM 1200 SuTthT HoyeO SvecI e4 AngF,a V(Ti4o328212.5050 Ww ETE =< Clariant.
refid# 2joGjOdgZ5MQKNjZ1Ok2RmjOr33 pages
AR 246 _ 1236 rSSoaebordntemnnnainaghs,h ipo 8 5h DuPont Engineering November 20, 2002 David P.
refid# OE1Yz5KYOLNDVBb3rq1eMp4Lp10 pages
foes R226 -- 359 SRPT T7001 MIN 315/022356 PERFLUOROOCTANESULFONYL FLUORIDE (POSF) T-Tebl> IN VITRO MAMMALIAN CHROMOSOME ABERRATION TEST IN HUMAN LYMPHOCYTES Sponsor 33MMCCeanrtpeorrt Toxicology SBiupilding T0250 UMsNa551333220 Page t0r3t ResearchLaboratory WHouomilnlgydRoenaLidfe Sciences Ld AHocnoinnbguiroyn PCeaamstradkgesire ENGLAND Reporsued 22 Osober 2002 001542 CONTENTS MIN3157022356 Page COMPLIANCEWITHGOODLABORATORY PRACTICESTANDARDS... 4 QUALITYASSURANCESTATEMENT. ccm eS RESPONSIBLE PERSONNEL... 6 INTRODUCTION sss 8 EXPERIMENTALPROCEDURE...
refid# jg18Gwr11BdJkOax2k2abGpZR28 pages